If the effective date of this final rule is delayed by 60 days, the MPFS for CY 2026 adopted in this final rule will not be effective at of the beginning of the payment year
Evaluating mouse models of hair-graying using genomic tools can reveal key aspects of melanocyte stem cell biology, said Harris
This is the simplest possible administration method
For further information on our current performance threshold policies, we refer readers to the CY 2017 Quality Payment Program final rule (81 FR 77333 through 77338), CY 2018 Quality Payment Program final rule (82 FR 53787 through 53792), CY 2019 PFS final rule (83 FR 59879 through 59883), CY 2020 PFS final rule (84 FR 63031 through 63037), CY 2021 PFS final rule (85 FR 84919 through 84923), CY 2022 PFS final rule (86 FR 65527 through 65532), CY 2023 PFS final rule (87 FR 70096 through 70100), CY 2024 PFS final rule (88 FR 79373 through 79380), and CY 2025 PFS final rule (89 FR 98448 through 98455)
Semaglutide Semaglutide is a synthetic GLP-1 receptor agonist with 94% homology to endogenous GLP-1